Beijing Plantai Pharmaceutical Technology Development

Beijing Plantai Pharmaceutical Technology Development is a Chinese pharmaceutical company focused on the research and development of innovative drugs, particularly in the field of pain management and gastrointestinal disorders. The company specializes in the development of opioid receptor agonists and antagonists designed to provide effective analgesia while minimizing side effects. Its lead programs include novel small molecules targeting postoperative pain and opioid-induced constipation. Plantai operates primarily within the Chinese domestic market, advancing candidates through clinical trials to meet unmet medical needs in anesthesia and pain relief.